Procter & Gamble Health peers

Companies like Procter & Gamble Healthlatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PGHL₹5,399.00

Procter & Gamble Health Limited

· Pharma & Health
₹ CrorePeersSANOFICONRSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹8,962 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
PGHL
FY27
SANOFICONR
FY26
SANOFI
FY25
SENORES
FY26
Peer
Average
Valuation — at last close
P/E93.21×31.87×◆ 16.67×50.18×32.91× +183%
P/B—19.90×8.00×◆ 6.53×11.48×
EV/EBITDA—23.52×◆ 13.42×37.41×24.78×
Market Cap₹8,962 Cr₹7,642 Cr₹6,882 Cr₹6,098 Cr₹6,874 Cr +30%
Growth
Revenue CAGR 3Y-33.37%————
Revenue CAGR 5Y-18.46%————
Net Income CAGR 3Y-25.17%————
Revenue YoY (latest Q)7.37%12.48%-25.80%◆ 18.90%1.86% +296%
Net Income YoY (latest Q)◆ 45.29%21.78%-33.70%21.51%3.20% +1317%
Profitability
EBITDA Margin27.38%◆ 35.18%24.38%26.61%28.72% -5%
Net Income Margin26.44%◆ 27.33%20.53%19.21%22.36% +18%
Return on Common Equity—◆ 73.09%44.07%14.13%43.76%
Return on Capital Employed—◆ 82.66%46.43%12.66%47.25%
Return on Assets—◆ 49.09%24.85%8.59%27.51%
Credit & Quality
Total Debt/Equity—◆ 0.00×0.00×0.34×0.11×
Interest Coverage◆ 668.43×148.65×302.73×5.48×152.29× +339%
Scale — latest FY
Revenue / Total Income₹364 Cr₹878 Cr₹2,013 Cr₹633 Cr₹1,175 Cr -69%
Net Income₹96.2 Cr₹240 Cr₹413 Cr₹122 Cr₹258 Cr -63%
Total Assets—₹547 Cr₹1,612 Cr₹1,604 Cr₹1,254 Cr
EPS₹57.92₹104.27₹179.46₹26.39₹103.37 -44%
Book Value per Share—₹166.96₹374.17₹202.74₹247.96
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY27 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.